Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
D DERMATOLOGICALS
D05 ANTIPSORIATICS
D05A ANTIPSORIATICS FOR TOPICAL USE
D05AX Other antipsoriatics for topical use
D05AX07 Tapinarof
D11365 Tapinarof (JAN/USAN) <JP/US>
USP drug classification [BR:br08302]
Dermatological Agents
Dermatological Agents, Other
Psoriasis Agents
Tapinarof
D11365 Tapinarof (JAN/USAN)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
26 Epidermides
269 Miscellaneous
2699 Others
D11365 Tapinarof (JAN/USAN)
Target-based classification of drugs [BR:br08310]
Not elsewhere classified
Signaling molecules
Transcription factor
AHR
D11365 Tapinarof (JAN/USAN) <JP/US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D11365
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D11365
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D11365